Screener
Astrana Health ASTH Noncontrolling interests in subsidiaries
Noncontrolling interests in subsidiaries at other companies
Other financials
Where this comes from
Reported directly by Astrana Health in its filing.
Tagged under the XBRL concept us-gaap:MinorityInterest.
The source filing: Astrana Health’s 10-Q, filed May 8, 2026.
- Filed
- May 8, 2026, 6:01 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-213157
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Preferred stock, $0.001 par value per share; 5,000,000 shares authorized; and zero shares issued and outstanding as of March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.001 par value per share; 100,000,000 shares authorized, 48,946,399 and 48,885,358 shares issued and outstanding, excluding 10,695,758 and 10,571,011 treasury shares, as of March 31, 2026 and December 31, 2025, respectively | 49 | 49 |
| Additional paid-in capital | 477,508 | 470,863 |
| Retained earnings | 322,711 | 308,379 |
| Total stockholders’ equity | 800,268 | 779,291 |
| Non-controlling interests | 14,927 | 14,005 |
| Total equity | 815,195 | 793,296 |
| Total liabilities, mezzanine deficit, and stockholders’ equity | $2,358,827 | $2,218,661 |
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FAQ
- What is Astrana Health's noncontrolling interests in subsidiaries?
- Astrana Health (ASTH) reported noncontrolling interests in subsidiaries of $14.93M in Q1 2026.
- How has Astrana Health's noncontrolling interests in subsidiaries changed year-over-year?
- Astrana Health's noncontrolling interests in subsidiaries increased by 194.4% year-over-year, from $5.07M to $14.93M.
- What is the long-term trend for Astrana Health's noncontrolling interests in subsidiaries?
- Over 5 years (2020 to 2025), Astrana Health's noncontrolling interests in subsidiaries has grown at a 176.3% compound annual growth rate (CAGR), from $87K to $14.01M.
- What does noncontrolling interests in subsidiaries mean?
- This represents the portion of a subsidiary's net assets that is owned by outside shareholders rather than the parent company. It is reported within equity to show the total value of the subsidiary's assets and liabilities that are not attributable to the parent. It reflects the non-controlling stake in consolidated entities.
Ask your AI about Astrana Health's noncontrolling interests in subsidiaries.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude